Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice.

Chang YC, Ching YH, Chiu CC, Liu JY, Hung SW, Huang WC, Huang YT, Chuang HL.

PLoS One. 2017 Jul 6;12(7):e0180025. doi: 10.1371/journal.pone.0180025. eCollection 2017.

2.

Early Gut Microbiota Intervention Suppresses DSS-Induced Inflammatory Responses by Deactivating TLR/NLR Signalling in Pigs.

Xiao Y, Yan H, Diao H, Yu B, He J, Yu J, Zheng P, Mao X, Luo Y, Chen D.

Sci Rep. 2017 Jun 12;7(1):3224. doi: 10.1038/s41598-017-03161-6.

3.

Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease.

Mottawea W, Chiang CK, Mühlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, Hajibabaei M, Singleton R, Benchimol EI, Jobin C, Mack DR, Figeys D, Stintzi A.

Nat Commun. 2016 Nov 23;7:13419. doi: 10.1038/ncomms13419.

4.

Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.

Vendramini-Costa DB, Francescone R, Posocco D, Hou V, Dmitrieva O, Hensley H, de Carvalho JE, Pilli RA, Grivennikov SI.

Carcinogenesis. 2017 Jan;38(1):51-63. doi: 10.1093/carcin/bgw112. Epub 2016 Oct 24.

5.

Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice.

Haarberg KM, Wymore Brand MJ, Overstreet AM, Hauck CC, Murphy PA, Hostetter JM, Ramer-Tait AE, Wannemuehler MJ.

World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):223-37. doi: 10.4292/wjgpt.v6.i4.223.

6.

Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota.

Nistal E, Fernández-Fernández N, Vivas S, Olcoz JL.

Front Oncol. 2015 Oct 12;5:220. doi: 10.3389/fonc.2015.00220. eCollection 2015. Review.

7.

A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse.

Keubler LM, Buettner M, Häger C, Bleich A.

Inflamm Bowel Dis. 2015 Aug;21(8):1967-75. doi: 10.1097/MIB.0000000000000468. Review.

8.

Control of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiota.

Dowds CM, Blumberg RS, Zeissig S.

Clin Immunol. 2015 Aug;159(2):128-33. doi: 10.1016/j.clim.2015.05.008. Epub 2015 May 16. Review.

9.

Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.

Yang YR, Kim DH, Seo YK, Park D, Jang HJ, Choi SY, Lee YH, Lee GH, Nakajima K, Taniguchi N, Kim JM, Choi EJ, Moon HY, Kim IS, Choi JH, Lee H, Ryu SH, Cocco L, Suh PG.

Oncotarget. 2015 May 20;6(14):12529-42.

10.

The gastrointestinal microbiota and colorectal cancer.

Keku TO, Dulal S, Deveaux A, Jovov B, Han X.

Am J Physiol Gastrointest Liver Physiol. 2015 Mar 1;308(5):G351-63. doi: 10.1152/ajpgi.00360.2012. Epub 2014 Dec 24. Review.

11.

The microbiota protects against ischemia/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling.

Perez-Chanona E, Mühlbauer M, Jobin C.

Am J Pathol. 2014 Nov;184(11):2965-75. doi: 10.1016/j.ajpath.2014.07.014. Epub 2014 Sep 6.

12.

Fusobacterium and Enterobacteriaceae: important players for CRC?

Allen-Vercoe E, Jobin C.

Immunol Lett. 2014 Dec;162(2 Pt A):54-61. doi: 10.1016/j.imlet.2014.05.014. Epub 2014 Jun 24. Review.

13.

Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis.

Yan Q, Sharma-Kuinkel BK, Deshmukh H, Tsalik EL, Cyr DD, Lucas J, Woods CW, Scott WK, Sempowski GD, Thaden JT, Rude TH, Ahn SH, Fowler VG Jr.

PLoS Pathog. 2014 Jun 5;10(6):e1004149. doi: 10.1371/journal.ppat.1004149. eCollection 2014 Jun. Erratum in: PLoS Pathog. 2014 Jun;10(6):e1004259. Thaden, Joshua [corrected to Thaden, Joshua T].

14.

The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Goldsmith JR, Sartor RB.

J Gastroenterol. 2014 May;49(5):785-98. doi: 10.1007/s00535-014-0953-z. Epub 2014 Mar 21. Review.

15.

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.

Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C.

Sci Rep. 2013 Oct 8;3:2868. doi: 10.1038/srep02868.

16.

Microbiota regulation of inflammatory bowel disease and colorectal cancer.

Liu Z, Cao AT, Cong Y.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):543-52. doi: 10.1016/j.semcancer.2013.09.002. Epub 2013 Sep 23. Review.

17.

CD137 facilitates the resolution of acute DSS-induced colonic inflammation in mice.

Martínez Gómez JM, Chen L, Schwarz H, Karrasch T.

PLoS One. 2013 Sep 4;8(9):e73277. doi: 10.1371/journal.pone.0073277. eCollection 2013.

18.

Redox signaling mediated by the gut microbiota.

Neish AS.

Free Radic Res. 2013 Nov;47(11):950-7. doi: 10.3109/10715762.2013.833331. Epub 2013 Oct 4. Review.

19.

Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse.

O'Carroll C, Moloney G, Hurley G, Melgar S, Brint E, Nally K, Nibbs RJ, Shanahan F, Carmody RJ.

Clin Exp Immunol. 2013 Aug;173(2):332-42. doi: 10.1111/cei.12119.

20.

The effects of TLR activation on T-cell development and differentiation.

Jin B, Sun T, Yu XH, Yang YX, Yeo AE.

Clin Dev Immunol. 2012;2012:836485. doi: 10.1155/2012/836485. Epub 2012 Jun 7. Review.

Supplemental Content

Support Center